|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.565 USD | +7.92% |
|
+9.37% | +26.64% |
| 01-05 | Altimmune, Inc. Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH | CI |
| 01-05 | Altimmune Says US FDA Grants Breakthrough Therapy Designation for Pemvidutide in MASH | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -4.31x | - | 0.16x | 98709.17x | -4.27x | -4.26x | - | 462M | |
| 45.34x | 7.21x | 1.96x | 10.86x | 38.84x | 40.1x | 0.02% | 49.24B | |
| 17.23x | 4.13x | 0.22x | 6.14x | 13.52x | 14.98x | 1.69% | 42.5B | |
| -27.64x | 93.03x | -4.45x | 60.6x | -31.68x | -29.74x | -.--% | 34.87B | |
| -26.54x | 1.21x | -1.19x | 4.45x | -12.13x | -9.6x | -.--% | 26.49B | |
| 30.66x | 2.84x | 0.8x | 6.04x | 16.74x | 20.85x | -.--% | 19.66B | |
| 16.91x | 3.25x | -6.35x | 4.25x | 11.27x | 11.97x | -.--% | 19.33B | |
| -407.81x | 12.74x | 7.14x | 27.93x | 659.38x | -447.61x | -.--% | 13.89B | |
| -192.39x | 23.58x | -2.44x | 45.66x | -185x | -163.82x | -.--% | 13.23B | |
| -12.36x | - | -0.04x | 154.27x | -24.05x | -12.04x | -.--% | 12.38B | |
| 16.74x | 4.51x | 0.34x | 4.81x | 11.83x | 13.12x | -.--% | 11.79B | |
| -46.31x | 19x | 0.92x | 11.52x | -44.95x | -42.03x | -.--% | 11.47B | |
| -18.53x | 16.4x | -0x | 20.58x | -26.07x | -18.71x | -.--% | 8.97B | |
| -18.51x | 7.98x | -0.41x | - | -19.04x | -18.4x | -.--% | 8.23B | |
| -167.3x | 20.36x | 2.05x | 18.77x | 575.43x | -164.51x | -.--% | 7.71B | |
| -10.04x | -13.96x | -0.48x | 90.59x | -12.26x | -12.02x | -.--% | 7.8B | |
| Average | -50.30x | 14.45x | -0.11x | 6,611.71x | 60.47x | -51.36x | 0.11% | 18B | |
| Weighted average by Cap. | -28.32x | 17.98x | -0.34x | 189.18x | 40.25x | -29.80x | 0.25% |
- Stock Market
- Equities
- ALT Stock
- Sector Altimmune, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition